Nika Pharmaceuticals, Inc.
corporate_fare Company Profile
Nika Pharmaceuticals, Inc. (OTC:NIKA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 5 items for NIKA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for NIKA spans 10-Q, 10-K.
Recent high-impact activity:
- Nika Q3: $352 Cash Left, Going Concern Doubt Reaffirmed, Controls Not Effective
- Nika Pharmaceuticals Discloses $2,932 in Cash, Reiterates Going Concern Warning, and Flags Ineffective Controls
- Nika Pharmaceuticals Reports Critical Cash Shortage, Going Concern, and Reverses Factory Acquisition
- Annual Report Reveals Going Concern, Ineffective Controls, and Auditor Instability
- Nika Pharmaceuticals Taps MD Global Partners for Strategic Growth, Capital Advisory
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 42 shares in NIKA as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.